SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ahlcon Parenterals to consider interim dividend

04 Feb 2012 Evaluate

Ahlcon Parenterals (India) has informed that a meeting of the board of directors of the company will be held on February 13, 2012, to consider and approve unaudited financial results for the third quarter ended on December 31, 2011 and Interim Dividend, if any, on the equity shares of the company for the financial year 2011-12.

The above information is part of company’s filing submitted to the BSE. 

Peers
Company Name CMP
Sun Pharma Inds. 1787.10
Dr. Reddys Lab 1271.75
Cipla 1376.25
Zydus Lifesciences 1097.90
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×